138 related articles for article (PubMed ID: 34321400)
1. Impact of Lisinopril on Cardiometabolic Risk Factors in Men With Hypertension and Early-onset Androgenetic Alopecia: A Pilot Study.
Krysiak R; Basiak M; Okopień B
J Cardiovasc Pharmacol; 2021 Nov; 78(5):e738-e742. PubMed ID: 34321400
[TBL] [Abstract][Full Text] [Related]
2. Impact of Lisinopril on Cardiometabolic Risk Factors in Sisters of Women With Polycystic Ovary Syndrome.
Krysiak R; Kowalcze K; Okopień B
J Clin Pharmacol; 2023 Sep; 63(9):1045-1052. PubMed ID: 37173821
[TBL] [Abstract][Full Text] [Related]
3. Impaired Cardiometabolic Effects of Bromocriptine in Men With Early-Onset Androgenic Alopecia.
Krysiak R; Basiak M; Szkróbka W; Okopień B
J Clin Pharmacol; 2023 Mar; 63(3):345-351. PubMed ID: 36222207
[TBL] [Abstract][Full Text] [Related]
4. Cardiometabolic Risk Factors in Rosuvastatin-Treated Men with Mixed Dyslipidemia and Early-Onset Androgenic Alopecia.
Krysiak R; Basiak M; Okopień B
Molecules; 2021 May; 26(10):. PubMed ID: 34064815
[TBL] [Abstract][Full Text] [Related]
5. The Impact of Atorvastatin on Cardiometabolic Risk Factors in Sisters of Women with Polycystic Ovary Syndrome.
Krysiak R; Kowalcze K; Okopień B
Pharmacology; 2023; 108(5):451-459. PubMed ID: 37536301
[TBL] [Abstract][Full Text] [Related]
6. The Impact of Telmisartan on Cardiometabolic Risk Factors in Hypertensive Male Siblings of Women With Polycystic Ovary Syndrome.
Krysiak R; Basiak M; Szkróbka W; Okopień B
J Clin Pharmacol; 2021 Sep; 61(9):1165-1173. PubMed ID: 33837974
[TBL] [Abstract][Full Text] [Related]
7. The impact of atorvastatin on cardiometabolic risk factors in brothers of women with polycystic ovary syndrome.
Krysiak R; Szkróbka W; Okopień B
Pharmacol Rep; 2021 Feb; 73(1):261-268. PubMed ID: 32696349
[TBL] [Abstract][Full Text] [Related]
8. Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: efficacy, tolerability and safety compared to an angiotensin-converting enzyme inhibitor, lisinopril.
Black HR; Graff A; Shute D; Stoltz R; Ruff D; Levine J; Shi Y; Mallows S
J Hum Hypertens; 1997 Aug; 11(8):483-9. PubMed ID: 9322828
[TBL] [Abstract][Full Text] [Related]
9. Impaired metabolic effects of metformin in men with early-onset androgenic alopecia.
Krysiak R; Kowalcze K; Okopień B
Pharmacol Rep; 2022 Feb; 74(1):216-228. PubMed ID: 34897595
[TBL] [Abstract][Full Text] [Related]
10. The effect of atorvastatin on cardiometabolic risk factors in women with non-classic congenital adrenal hyperplasia: A pilot study.
Krysiak R; Kowalcze K; Bednarska-Czerwińska A; Okopień B
Pharmacol Rep; 2019 Jun; 71(3):417-421. PubMed ID: 31003151
[TBL] [Abstract][Full Text] [Related]
11. Effect of indomethacin on the antihypertensive efficacy of valsartan and lisinopril: a multicentre study.
Fogari R; Zoppi A; Carretta R; Veglio F; Salvetti A;
J Hypertens; 2002 May; 20(5):1007-14. PubMed ID: 12011663
[TBL] [Abstract][Full Text] [Related]
12. Lisinopril for the treatment of hypertension within the first 24 hours of acute ischemic stroke and follow-up.
Eveson DJ; Robinson TG; Potter JF
Am J Hypertens; 2007 Mar; 20(3):270-7. PubMed ID: 17324738
[TBL] [Abstract][Full Text] [Related]
13. Additive effects of diltiazem and lisinopril in the treatment of elderly patients with mild-to-moderate hypertension.
Chan P; Lin CN; Tomlinson B; Lin TH; Lee YS
Am J Hypertens; 1997 Jul; 10(7 Pt 1):743-9. PubMed ID: 9234828
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the efficacy and tolerability of nebivolol versus lisinopril in the treatment of essential arterial hypertension: a randomized, multicentre, double-blind study.
Rosei EA; Rizzoni D; Comini S; Boari G;
Blood Press Suppl; 2003 May; 1():30-5. PubMed ID: 12800985
[TBL] [Abstract][Full Text] [Related]
15. Effects of dual blockade of the renin-angiotensin system in primary proteinuric nephropathies.
Luño J; Barrio V; Goicoechea MA; González C; de Vinuesa SG; Gómez F; Bernis C; Espinosa M; Ahijado F; Gómez J; Escalada P
Kidney Int Suppl; 2002 Dec; (82):S47-52. PubMed ID: 12410855
[TBL] [Abstract][Full Text] [Related]
16. [A comparative study of the efficacy of lisinopril versus quinapril in controlling light to moderate arterial hypertension. A follow-up with ABPM].
Motero Carrasco J
Rev Esp Cardiol; 1995 Nov; 48(11):746-53. PubMed ID: 8532944
[TBL] [Abstract][Full Text] [Related]
17. Comparative effect of lisinopril and lacidipine on urinary albumin excretion in patients with type 11 diabetic nephropathy.
Salako BL; Finomo FO; Kadiri S; Arije A; Olatosin AO
Afr J Med Med Sci; 2002 Mar; 31(1):53-7. PubMed ID: 12518931
[TBL] [Abstract][Full Text] [Related]
18. [Ambulatory monitoring of arterial pressure in the treatment of mild-moderate arterial hypertension with lisinopril vs. enalapril].
Motero Carrasco J
Arch Inst Cardiol Mex; 1997; 67(1):29-37. PubMed ID: 9221708
[TBL] [Abstract][Full Text] [Related]
19. Comparison of rilmenidine and lisinopril on ambulatory blood pressure and plasma lipid and glucose levels in hypertensive women with metabolic syndrome.
Anichkov DA; Shostak NA; Schastnaya OV
Curr Med Res Opin; 2005 Jan; 21(1):113-9. PubMed ID: 15881482
[TBL] [Abstract][Full Text] [Related]
20. Effects of manidipine and its combination with an ACE inhibitor on insulin sensitivity and metabolic, inflammatory and prothrombotic markers in hypertensive patients with metabolic syndrome: the MARCADOR study.
Martinez-Martin FJ; Macias-Batista A; Comi-Diaz C; Rodriguez-Rosas H; Soriano-Perera P; Pedrianes-Martin P
Clin Drug Investig; 2011; 31(3):201-12. PubMed ID: 21155616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
